(MedPage Today) — Control group outcomes in randomized trials of psilocybin indicated less improvement in depression scores compared with trials of other antidepressants, according to a meta-analysis, suggesting that psilocybin’s efficacy may…
Source link : https://www.medpagetoday.com/psychiatry/depression/116748
Author :
Publish date : 2025-07-30 19:36:00
Copyright for syndicated content belongs to the linked Source.
